Researchers Identify Protein Site Used by Pseudorabies
The finding reveals a specific protein subdomain required for viral entry, marking a new potential target for antiviral research.
Updated on Oct. 28, 2026 in Life Sciences
Researchers have identified a specific segment of the protein NMHC IIA as the entry point for the pseudorabies virus (PRV). This finding, published in the Journal of Virology, clarifies the mechanism by which the virus hijacks cellular proteins to initiate infection.
Why it matters
By pinpointing the molecular docking site required for viral entry, this research establishes a concrete target for potential future antiviral therapies against PRV. Understanding these translocation processes is essential for developing interventions that can block viral internalization before infection takes hold.
The study isolates the 1831-1882 amino acid (aa) subdomain within the C-terminus of NMHC IIA (aa 1672-1981) as the binding site for viral glycoproteins gH and gL. Targeted inhibition of this protein in PK-15 cells demonstrated a dose-dependent reduction in PRV infection.
The details
During early infection, NMHC IIA—a non-muscle myosin heavy chain protein—translocates from the cell cytoplasm to the surface. The virus exploits this movement by binding its glycoproteins gH and gL to the sPRA subdomain of NMHC IIA. Researchers confirmed this mechanism by employing chemical inhibitors, siRNA-mediated knockdown, and anti-sPRA serum to block the interaction, effectively preventing the virus from internalizing.
Timeline
October 28, 2026: Study findings were published in the Journal of Virology.
The Tech Race
This finding sits within the ongoing effort to map the molecular entry pathways used by the Herpesviridae family of viruses. It advances the research trajectory by isolating a specific host-cell protein segment, providing a clearer target than previous broad-spectrum viral inhibitors.
This is a basic research finding and does not currently impact clinical practice or animal health diagnostics. Scientists and developers in virology can now use this specific protein subdomain as a target for screening new potential antiviral drug candidates.
The takeaway
This study identifies a precise molecular bottleneck that pseudorabies viruses must pass through to successfully infect host cells. Future research will likely focus on whether small-molecule inhibitors can effectively target the 1831-1882 amino acid subdomain in live animal models.
Further reading
For broader context on viral entry mechanisms, explore the Life Sciences section.
Source note: This article includes information reported by Journal of Virology.
